Skip to content

Effect of everyother day dosing regimen of latanoprost on intraocular pressure

Intraocular Pressure Lowering Effect of 0.005% Latanoprost With Two Different Dosing Regimen

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201102265905N1
Enrollment
40
Registered
2011-04-10
Start date
2008-07-05
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma. Ocular Hypertension,primary open angle glaucoma

Interventions

Intervention 1: Eyedrop latanoprost 0.005% once daily at 9 PM in one eye (group 1) and every other day dose in the other eye (group 2) at month1. Intervention 2: Eyedrop latanoprost 0.005% once daily
Treatment - Drugs
Eyedrop latanoprost 0.005% once daily at 9 PM in one eye (group 1) and every other day dose in the other eye (group 2) at month1.
Eyedrop latanoprost 0.005% once daily at 9 PM in one eye (group 2) and every other day dose in the other eye (group 1) at month 2.

Sponsors

Eye research center,Rassoul Akram Hospital, Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to No maximum

Inclusion criteria

Inclusion criteria: The inclusion criteria are: Age =30 years, IOP =22 and =32 mmHg without any IOP lowering medication, cup to disc ratio =0.6, mean deviation of = -6 decibel in perimetry and open angles on gonioscopy. Patients with a history of prior ocular surgery, uveitis, herpetic keratitis, and allergy to latanoprost are excluded

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Intraocular pressure (IOP). Timepoint: 24 hours before instillation of latanoprost, baseline IOP was measured 3 times ,at 9AM,4PM,and 9PM and again after one and two months of drug usage,based on assigned protocol of drug instillation,were measured at the same time points. Method of measurement: Calibrated Goldmann applanation tonometer.

Secondary

MeasureTime frame
Side effects related to drug. Timepoint: At each time visit after instillation of drug ,during 2-month period of study. Method of measurement: Anterior segment exam by slit lamp biomicroscopy,posterior segment exam by funduscopy lenses, visual acuity test by Snellen chart and patients own description of side effects like significant Itching,redness and burning sensation.

Countries

Iran (Islamic Republic of)

Contacts

Public Contactnaveed Nilforushan

Eye research center,Rassoul akram Hospital Tehran University of Medical Sciences

n-nilforushan@tums.ac.ir+98 21 6650 9162

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026